HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
In This Section
Alexis Thompson
Chief, Division of Hematology
Dr. Thompson is the chief of the Division of Hematology at CHOP and holds the Elias Schwartz, MD, Endowed Chair in Hematology. Her research focuses on sickle cell disease and thalassemia.
Education and Training
BS, Pomona College (Zoology), 1979
MD, Tulane University School Of Medicine, 1983
Internship, Children's Hospital of Los Angeles (Pediatrics)
Residency, Children's Hospital of Los Angeles (Pediatrics)
Fellowship, Children's Hospital of Philadelphia (Pediatric Hematology/Oncology)
MPH, University Of California (Health Services), Los Angeles, 1987
Titles and Academic Titles
Chief, Division of Hematology
Professor of Pediatrics
Professional Memberships
American Society of Hematology
- President, 2018
- Vice President, 2015-2016
- Sickle Cell Disease Task Force, 2009-
- Government Affairs Committee, 2006-
Cure Sickle Cell Initiative
-Chair, Clinical Trials Design Subcommittee, 2018-
- Steering Committee, 2018-
National Medical Association
American Society of Pediatric Hematology-Oncology
American Society of Genetic and Cell Therapy
European Hematology Association
Professional Awards
Exceptional Women in Medicine, Chicago Magazine, 2021
Top Blacks in Healthcare, blackdoctors.org, 2020
Distinguished Alumni Award, Champions of Healthcare, National Medical Fellowships, 2020
Cage S. Johnson, Sickle Cell Physician Award, Cayenne Wellness, 2020
Faculty Excellence in Leadership Award, Lurie Children’s Hospital (inaugural recipient), 2019
Alexander S. Weiner Memorial Lecture, New York Blood Center, 2019
Gwynne Hazen Cherry Family/Stephen A. Feig, M.D. Endowed Lecturer, UCLA Mattel Children’s Hospital, 2019
Paul M. Aggeler Lecture, UCSF/ZSFGH, San Francisco, 2018
William C. Moloney Lecture, Brigham and Women’s Hospital, Boston, 2018
Alpha Omega Alpha National Medical Honor Society (faculty inductee), 2018
Publication Highlights
Ozelo MC, Mahlangu J, Pasi KJ, Giermasz A, Leavitt AD, Laffan M, Symington E, Quon DV, Wang JD, Peerlinck K, Pipe SW, Madan B, Key NS, Pierce GF, O'Mahony B, Kaczmarek R, Henshaw J, Lawal A, Jayaram K, Huang M, Yang X, Wong WY, Kim B; GENEr8-1 Trial Group. Valoctocogene Gene Therapy for Hemophilia A. N Engl J Med. 2022 Mar; 386(11): 1013-1025. PMID: 35294811
Kanter J, Walters MC, Krishnamurti L, Mapara MY, Kwiatkowski JL, Rifkin-Zenenberg S, Aygun B, Kasow KA, Pierciey FJ Jr, Bonner M, Miller A, Zhang X, Lynch J, Kim D, Ribeil JA, Asmal M, Goyal S, Thompson AA, Tisdale JF. Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. N Engl J Med. 2022 Feb; 386(7):617-628. PMID: 34898139
Locatelli F, Thompson AA, Kwiatkowski JL, Porter JB, Thrasher AJ, Hongeng S, Sauer MG, Thuret I, Lal A, Algeri M, Schneiderman J, Olson TS, Carpenter B, Amrolia PJ, Anurathapan U, Schambach A, Chabannon C, Schmidt M, Labik I, Elliot H, Guo R, Asmal M, Colvin RA, Walters MC. Autotemcel Gene Therapy for Non-β0/β0 Genotype β-Thalassemia. N Engl J Med. 2022 Feb; 386(5): 415-427. PMID: 34891233
Badawy SM, Payne AB, Hulihan MM, Coates TD, Majumdar S, Smith D, Thompson AA. Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Control. Br J Haematol. 2021 Dec; 195(5): e160-e164. PMID: 34431082
O'Connor FG, Franzos MA, Nye NS, Nelson DA, Shell D, Voss JD, Anderson SA, Coleman NJ, Thompson AA, Harmon KG, Deuster PA. Summit on Exercise Collapse Associated with Sickle Cell Trait: Finding the "Way Ahead". Curr Sports Med Rep. 2021 Jan; 20(1): 47-56. PMID: 33395130